Vanderbilt-Ingram Cancer Center

MyCancerGenome, the online medical decision support tool for cancer care developed by Vanderbilt physician-scientists, has been selected as a finalist for a health care technology award. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” is sponsored by the National Cancer Institute (NCI), Division of Cancer Control and [...]

Lung cancer is the No. 1 cancer killer for both men and women in the United States, claiming more lives than breast, prostate and colon cancers combined. Yet the disease gets far less attention and generates less fundraising activity than other forms of cancer. This year, there will be a coordinated effort to change that [...]

William Pao, M.D., Ph.D., associate professor of Medicine and director of Personalized Cancer Medicine at Vanderbilt, has been named director of the Division of Hematology and Oncology in the Department of Medicine. “Dr. Pao has demonstrated tremendous leadership and creativity since arriving at Vanderbilt,” said Nancy Brown, M.D., chair and physician-in chief of the Department [...]

A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that various non-small cell lung cancer (NSCLC) cells grow at different rates, which may explain why some tumors become resistant to anti-cancer drugs faster than others. Based on the differential growth rates, the study suggests that a change in the timing and dosages [...]

Breast cancer patients at Vanderbilt-Ingram Cancer Center can now have their tumor tissue tested for gene mutations that are important for treatment decisions. Information from genetic tests in the tumors will be used to match patients to the best cancer therapies available, including drugs that are in early clinical trial testing. Tumor mutation testing for [...]

Since the first of the year, one cutting-edge sequencer, the Illumina HiSeq 2000, has been installed in a lab in the Preston Research Building, and another has been delivered. More than 30 Vanderbilt investigators have submitted samples for sequencing by the machines, which are not much bigger than half-size refrigerators.“The access to this technology allows [...]

Christine Lovly, M.D., Ph.D., a fellow in the Division of Hematology/Oncology at Vanderbilt-Ingram Cancer Center (VICC), has been selected to receive a 2011 Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). The $50,000 grant will help fund Lovly’s research on the molecular mechanisms that alter the effectiveness [...]

William Pao, M.D., Ph.D., and Fernando Polack, M.D., have been elected into one of the nation’s most respected medical honor societies — the American Society for Clinical Investigation (ASCI). Pao, the Ingram Associate Professor of Cancer Research, and Polack, the Cesar Milstein Associate Professor of Pediatrics, were among 70 new members introduced at the ASCI [...]

Lynn Matrisian, Ph.D., chair of the Department of Cancer Biology, has been named to the Nominating Committee for the American Association for Cancer Research (AACR). The announcement was made during the AACR annual meeting held earlier this month in Orlando, Fla. Matrisian has served as AACR president from 2004-2005, as a member of the board [...]

Vanderbilt-Ingram Cancer Center has launched the nation’s first personalized cancer decision support tool, “My Cancer Genome,” to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients. This web-based information tool is designed to quickly educate clinicians on the rapidly expanding list of genetic [...]